Resources search

International drug price indicator guide|Guia internacionale de indicadores de precios de medicamentos|Indicateur de prix internationaux des medicaments|2008

FRYE, Julie E

Expand view

This guide contains a spectrum of prices from pharmaceutical suppliers, international development organisations, and government agencies. Its aim is to make price information more widely available in order to improve procurement of medicines of assured quality for the lowest possible price. Comparative price information is important for getting the best price, and this is an essential reference for anyone involved in the procurement of pharmaceuticals. This guide will help to: * Determine the probable cost of pharmaceutical products; * Compare current prices paid to prices available on the international market; * Plan budgets and programmes; * Assess the potential financial impact of changes to your current medicines list, and * Support rational medicines use education

Measuring medicine prices, availability, affordability and price components


Expand view

This manual is to help governments, civil society groups and others concerned about the prices of medicines to collect and analyse: medicine prices (patient prices and government procurement prices) across sectors and regions in a country; medicine availability; treatment affordability; and all price components in the supply chain from manufacturer to patient (taxes, mark-ups etc.). It is accompanied by a CD-ROM which contains a more extensive collection resources and tools, such as sample training materials, frequently asked questions, and a report template for use in developing national survey reports

Guidelines for price discounts of single-source pharmaceuticals

WORLD HEALTH ORGANIZATION (WHO). Essential Drugs and Medicines Policy
et al

Expand view

These guidelines are designed to maximise the benefit of price discounts arrangements for single-source products. They are intended for policy makers and technical staff in international and bilateral agencies active in international health development support, for pharmaeutical companies and for governments and NGOs in recipient countries. It highlights a number of issues that WHO feels need to be considered when planning or negotiating offers of price discounts


Source e-bulletin on Disability and Inclusion

Subscribe to updates